NEXPLANON 68 mg, implant for subcutaneous use implant
Active ingredients: Etonogestrel
Commercialized according to BDPMDispensing in France: Prescription only
Implantimplantsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEXPLANON 68 mg, implant pour usage sous-cutané
- Pharmaceutical form
- implant
- Route of administration
- sous-cutanée
- Presentation description
- plaquette(s) thermoformée(s) PETG (polyéthylène téréphtalate glycol) de 1 implant avec applicateur acrylonitrile butadiène styrène avec aiguille acier inoxydable
- Marketing authorisation holder
- ORGANON FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 May 2001
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66845924CIP73515443CIP133400935154439Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTONOGESTRELimplant | 68 mg · un implant | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.